The finding that NDR1 antagonizes TGFβ-induced cell cycle arrest in epithelial suggests that cancer cells may employ an NDR1-dependent mechanisms to evade the tumor suppressive effect of TGFβ. The gene discussed is STK38; the disease is neoplasm.